Peptides for Muscle Growth: The Compounds, the Evidence, and the What FDA Flagged

Growth hormone “secretagogues” — sermorelin, tesamorelin, CJC-1295, and the GHRPs like ipamorelin — are compounds that prompt your pituitary gland, the small gland at the base of your brain, to release more of your own growth hormone. ⚠

They are not growth hormone itself, and they are not steroids. They range from an FDA-approved prescription drug (tesamorelin) to a once-approved, now-discontinued drug (sermorelin) to compounds the FDA has flagged as presenting significant safety risks in compounding (ipamorelin, GHRP-2, GHRP-6, and the non-peptide MK-677/ibutamoren).

The honest answer to “do they build muscle” is tricky: The best human data shows real gains in lean mass, but not the strength gains people expect from them, which is a distinction worth understanding before looking at any single compound.

That gap between “more lean mass on a scan” and “more strength in your hands” is the whole story on this page, and it’s the part most articles on this topic skip.

What growth hormone secretagogues actually are

A secretagogue is simply something that makes a gland release — secrete — more of a substance it already produces on its own. These compounds don’t add growth hormone to your body. They signal your pituitary to put out more of yours.

If you’re new to this whole category, it helps to first understand what peptides actually are — A short chains of amino acids, the same building blocks that make up proteins.

When people search for “HGH peptides” or “growth hormone peptides,” this is the group they mean. It splits into three types.

GHRH analogues. Your brain naturally makes a signal called growth hormone-releasing hormone (GHRH), which tells your pituitary to release growth hormone. A GHRH analogue is a lab-made copy of that signal. Sermorelin, tesamorelin, and CJC-1295 belong here.

GHRPs, also called ghrelin receptor agonists. These work through a different switch. Ghrelin is the hormone best known for making you feel hungry, and it also happens to trigger growth hormone release when it docks onto its receptor. GHRPs press that same switch. Ipamorelin, GHRP-2, and GHRP-6 belong here.

The one non-peptide in the group. MK-677, also called ibutamoren, isn’t a peptide at all. It’s an oral ompound, meaning you swallow it rather than inject it, and it works on that same ghrelin receptor pathway.

It gets discussed alongside the peptides because people search for it in this category and because FDA’s own flagged-substances list groups it with the GHRPs.

Two distinctions matter before you go further …

These are not HGH. Human growth hormone is the hormone itself, manufactured and injected directly. Secretagogues are upstream of that … They ask your gland to do the work, which is why their effect is limited by how much your own pituitary can actually produce.

And these are not the peptides people take for recovery. If you landed here looking for joint or tendon repair, BPC-157 and the tissue-repair family are a genuinely separate category from the growth-hormone-axis compounds this article covers — different mechanism, different evidence base, different regulatory picture.

Do muscle building peptides actually work? What the human trials show

Yes, measurably — but for lean mass, not for strength. That’s the single most important finding in the human evidence, and it’s remarkably consistent across the two best studies we have.

The MK-677 trial. Nass and colleagues ran a 12-month randomized controlled trial of an oral ghrelin mimetic — MK-677 — in healthy older adults, published in Annals of Internal Medicine in 2008. Fat-free mass (everything in your body that isn’t fat: muscle, bone, organs, water) rose by 1.1 kg in the treated group and fell by 0.5 kg on placebo, a difference the researchers reported at p<0.001, meaning it’s very unlikely to be a fluke. Their own conclusion is the line worth reading twice: “increased fat-free mass did not result in changes in strength or function.” (Nass R, et al. Ann Intern Med. 2008;149(9):601-11. PMID 18981485)

The growth hormone review. Liu and colleagues pooled 27 randomized controlled trials covering 440 participants, looking at what growth hormone itself does to athletic performance, also in Annals of Internal Medicine in 2008. Lean body mass went up 2.1 kg versus control. Strength did not significantly improve. Side effects were common: soft-tissue swelling — fluid puffiness in the hands, feet, and face — in 44% of participants versus 1% on placebo, and fatigue in 35% versus 0%. (Liu H, et al. Ann Intern Med. 2008;148(10):747-758. PMID 18347346)

That second study is about growth hormone directly, not secretagogues, which makes it a useful ceiling: it shows what happens when you maximize the very thing these compounds are trying to nudge upward. If the hormone itself doesn’t reliably produce strength gains, it’s hard to argue a compound that asks your body to make a bit more of it will.

It’s also worth understanding why lean mass can go up, while strength stays flat. Lean mass measurements include water, and the same body of research that found the lean-mass gains also found swelling in nearly half of participants — so at least some of what the scan is counting may be fluid rather than working muscle tissue.

For a broader look at what’s been established across this whole compound class, Sigalos and Pastuszak’s review in Sexual Medicine Reviews (PMID 28400207) is the standard category-level summary.

Peptides vs. steroids: how they’re actually different

They’re different at the level of what they act on, not just different in degree. Anabolic steroids are synthetic versions of testosterone. Growth hormone secretagogues aren’t hormones you’re adding at all — they’re signals that ask your own pituitary gland to release more of a completely different hormone.

Here’s the difference …

An anabolic steroid enters your cells and binds to the androgen receptor, the same docking point testosterone uses. That directly drives muscle protein synthesis — the process of building new muscle fiber — and the more you take, the harder you push that lever. There’s no natural ceiling built into it.

A secretagogue does something structurally different. It signals the gland, and your pituitary still releases growth hormone the way it normally does — in pulses, with your body’s own feedback systems still switching it off when levels get high. That built-in brake is the main reason these compounds produce more modest effects than steroids do, and it’s also why the outcome data above looks the way it does.

The legal picture is different too, and in a direction people often get backwards. Anabolic steroids are Schedule III controlled substances under federal law (21 U.S.C. § 812, Schedule III(e)) — possessing them without a prescription is a federal offense. Growth hormone secretagogues are not controlled substances. That’s a real difference, but it does not mean they’re approved, tested, or unregulated in your favor — see the regulatory section below for what each one’s actual status is.

On the question people really want answered — are peptides safer than steroids — the honest answer is that “safer” hasn’t been established. What’s established is that they have different risk profiles, and that the long-term safety data on secretagogues in healthy adults seeking muscle growth is thin compared to decades of accumulated clinical experience with testosterone. Less studied is not the same as safer.

The compounds, compared:

This is the part worth bookmarking. Status is stated as of September 2026.

Sources for the regulatory column: FDA’s Certain Bulk Drug Substances list; Drugs@FDA ApplNo 022505 (EGRIFTA, approved 11/10/2010, deemed a BLA 03/23/2020); Drugs@FDA ApplNo 019863 (GEREF, approved 12/28/1990, marketing status discontinued).

One note on that flagged list: it currently contains 14 substances total, and four of them are compounds from this article. That’s not an accident of paperwork — it means FDA looked at these specific substances in the context of pharmacy compounding and concluded they may present significant safety risks.

Is MK-677 a peptide?

No. MK-677 — also sold under the name ibutamoren — is an oral non-peptide compound. Peptides are short chains of amino acids and generally can’t survive digestion, which is why nearly everything else in this article is injected. MK-677 is a small molecule you swallow.

It belongs in this article anyway, for two reasons. It works on the same ghrelin receptor pathway as the GHRPs, so it produces the same kind of effect through the same door. And FDA’s own flagged-substances list groups ibutamoren mesylate right alongside ipamorelin acetate, GHRP-2, and GHRP-6 — the agency treats it as part of the same category even though the chemistry is different.

If you see it marketed as a “growth hormone peptide,” that’s not a technicality worth ignoring. It tells you something about how carefully the seller is handling the rest of their claims.

What “the best peptide for muscle growth” actually means

There isn’t a best one, and any page that hands you a ranked list is telling you more about its business model than about the evidence. We don’t make compound recommendations here.

What we can give you is the thing a ranking hides: what’s actually been measured, and what each compound’s legal status actually is.

Measured in humans, over 12 months, with a placebo group: MK-677, which produced 1.1 kg of fat-free mass and explicitly no strength or function change. Approved by FDA for a specific medical condition, with the trial data that approval requires: tesamorelin — for reducing excess abdominal fat in HIV-associated lipodystrophy, which is not a muscle-building indication. Everything else in the table has thinner human evidence than most marketing implies, and four of those compounds sit on an FDA list of substances that may present significant safety risks in compounding.

Put those two columns side by side and “best” stops being a useful question. The useful questions are: what has this been shown to do in people, and what is its legal status today.

If what you’re actually after is body recomposition — losing fat while holding onto muscle — the compounds with the strongest human data aren’t in this category at all. That’s the GLP-1 peptides for weight loss, which work through an entirely different pathway. And if your interest is specifically competitive bodybuilding, the questions there are different enough — contest prep, testing, stacking — that they deserve their own treatment rather than a paragraph here.

Where these compounds sit legally right now

There is no single answer, because these compounds don’t share one legal status. Here is each one, plainly.

Tesamorelin is an FDA-approved prescription drug, sold as EGRIFTA, as of September 2026. It’s been regulated as a biologic since being deemed a Biologics License Application in March 2020.

Sermorelin is an FDA-approved drug whose marketing status is discontinued, as of September 2026. FDA’s own record notes it was not withdrawn for reasons of safety or effectiveness — the manufacturer simply stopped selling it.

Ipamorelin, GHRP-2, GHRP-6, and ibutamoren mesylate (the compound sold as MK-677) are substances on FDA’s list of bulk drug substances that may present significant safety risks in compounding, all added September 29, 2023, as of September 2026. Compounding is when a licensed pharmacy mixes a drug to order rather than dispensing a mass-manufactured product — and this list is FDA telling those pharmacies these particular substances raise safety concerns.

CJC-1295 is a compound that appears on that same FDA compounding page only in the withdrawn-nominations table, as of September 2026, alongside a note about immunogenicity risk and, for certain administration routes, reports of increased heart rate and systemic vasodilatory reaction.

There’s one more statute people cite in these conversations, and it needs stating carefully. 21 U.S.C. § 333(e) makes it a federal offense to distribute or possess with intent to distribute human growth hormone for any use not authorized by the Secretary and not pursuant to a valid prescription. The statute’s literal terms name “somatrem, somatropin, or an analogue of either” — that is, growth hormone itself. It does not name growth hormone secretagogues. Whether it reaches these compounds is a question for a lawyer, and we’re not going to assert an answer either way.

Who actually sells these, and what that channel guarantees

This matters as much as the legal status, because the channel determines what protections you do and don’t have.

Tesamorelin comes one way: a prescription from a licensed clinician, filled at a licensed pharmacy. That channel gives you FDA-inspected manufacturing, a verified dose, a label that has been through FDA review, and a clinician supervising the decision.

Sermorelin has no FDA-approved product on the U.S. market today. What people receive is compounded — prepared by a compounding pharmacy, usually arranged through a telehealth clinic or medspa. A licensed compounding pharmacy operates under state and federal rules and a clinician is involved, which is real. But a compounded preparation is not an FDA-approved drug: it has not been reviewed by FDA for safety and effectiveness, and its strength and purity depend on that specific pharmacy’s practices rather than on FDA pre-market review.

Ipamorelin, GHRP-2, GHRP-6, CJC-1295, and MK-677 are sold mainly by websites that label their products “research use only” and ship direct to consumers with no prescription and no clinician involved. That phrase is not an FDA category, an approval, or a clearance. It is a labeling choice by the seller, and it guarantees nothing about purity, dosing accuracy, sterility, or what’s actually in the vial. It also doesn’t create any legal protection for the buyer. FDA has issued warning letters to sellers in this space — a June 17, 2026 letter to Wholesale Peptide is one recent example of the agency’s enforcement posture toward “research use only” labeling generally.

None of that means every product from that channel is contaminated, and we’re not going to pretend we know that. It means the ordinary guardrails — someone verifying the dose, someone checking sterility, someone medically responsible if it goes wrong — are not present. Being purchasable online is a fact about distribution. It isn’t a statement about safety, quality, or legality.

FAQs about Peptides for Muscle Growth